Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2bfy | H1N | Aurora kinase B-A | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 1.000 | |
| 2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.546 | |
| 2vgp | AD6 | Aurora kinase B-A | 2.7.11.1 | 0.522 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.507 | |
| 2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.499 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.499 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.491 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.490 | |
| 3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.490 | |
| 4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.489 | |
| 2j4z | 626 | Aurora kinase A | 2.7.11.1 | 0.488 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.488 | |
| 3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.487 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.485 | |
| 2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
| 2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.477 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.477 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.474 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.473 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.473 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.473 | |
| 5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.473 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.472 | |
| 3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.471 | |
| 4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.471 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
| 3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.470 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.470 | |
| 4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.470 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.469 | |
| 3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.468 | |
| 2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.467 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.465 | |
| 2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
| 2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.464 | |
| 2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.464 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.464 | |
| 3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.464 | |
| 2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.463 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.463 | |
| 4ix6 | ADP | Uncharacterized protein | / | 0.462 | |
| 2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.461 | |
| 4bdi | HAU | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.461 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.460 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.460 | |
| 4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
| 4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
| 2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.459 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.458 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.458 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.457 | |
| 2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.457 | |
| 2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.457 | |
| 4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.457 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.457 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.456 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.455 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.455 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.455 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.455 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.455 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.455 | |
| 1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.454 | |
| 4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.454 | |
| 4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.454 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.454 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.453 | |
| 3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.453 | |
| 4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.453 | |
| 4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.453 | |
| 4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.452 | |
| 5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.452 | |
| 1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
| 2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
| 4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.451 | |
| 4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.451 | |
| 5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.451 | |
| 2w1e | L0E | Aurora kinase A | 2.7.11.1 | 0.450 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.450 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
| 4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.450 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.450 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.449 | |
| 2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.449 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.448 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
| 3w16 | P9J | Aurora kinase A | 2.7.11.1 | 0.448 | |
| 3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.448 | |
| 1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.447 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.447 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.447 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.447 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 4zoh | FAD | Putative oxidoreductase FAD-binding subunit | / | 0.447 | |
| 1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 4jaj | XU1 | Aurora kinase A | 2.7.11.1 | 0.446 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.445 | |
| 3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.445 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.445 | |
| 4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.445 | |
| 2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.444 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.444 | |
| 4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.444 | |
| 4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.444 | |
| 1i7i | AZ2 | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
| 2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
| 4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.443 | |
| 4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.443 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.443 | |
| 4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.443 | |
| 1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
| 1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
| 3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.442 | |
| 3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
| 4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4l7f | 1V5 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.442 | |
| 2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
| 3slk | NDP | Polyketide synthase extender module 2 | / | 0.441 | |
| 4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.441 | |
| 4i4e | 1BQ | Focal adhesion kinase 1 | 2.7.10.2 | 0.441 | |
| 2aqh | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
| 2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 3lin | E13 | Protease | / | 0.440 | |
| 4b0g | VEK | Aurora kinase A | 2.7.11.1 | 0.440 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
| 4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.440 | |
| 4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.440 | |
| 5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.440 |